Board of Directors
Stanley Lapidus, President, CEO and Founder
Stan is an experienced life-science entrepreneur and inventor with over 30 issued US patents. He founded and led Cytyc, EXACT Sciences and Helicos BioSciences (NASDAQ: CYTC, EXAS, HLCS), and holds academic appointments at Tufts and MIT. Since 2002, Stan has served as a trustee of Cooper Union, his alma mater.
Robert Carpenter is Chairman of Hydra Biosciences Inc., a company he helped found which is conducting research in a new class of ion channels. Previously, he served as Executive Vice President of Genzyme Corporation, and founded two life sciences companies, Integrated Genetics and GelTex Pharmaceuticals, that went public and were acquired by Genzyme. He was a Director of Genzyme from 1994 to 2010 and held the position of Lead Director from 2008 to 2010. In 2002, Mr. Carpenter also helped spin out a subsidiary of Genzyme called Peptimmune Inc., of which he was Chairman of the Board until 2007. He currently serves as a director of Moderna, Good Start Genetics, SynapDx and Immuneering Inc.. He holds a BA from the United States Military Academy at West Point, an MS in Computer Science from Stanford University, and an MBA from Harvard University.
William Geary, North Bridge Venture Partners, Partner
Bill has been with North Bridge since inception in 1994, a leading early-stage venture capital and growth equity investment firm with $3B under management. He invests primarily in healthcare technology. North Bridge investments include Humedica, Healthrageous, Connance, Valence Health, SynapDx, Aushon Biosystems, 480Biomedical, Infomedics, Phase Forward, Pharmetrics, NaviNet and eBenX. Bill is former Chair of Boston College's Board of Trustees and is a member of its Investment & Endowment Committee. He currently serves on the Advisory Boards of the Center For Connected Health at Partners HealthCare, the Technology Fund of Children’s Hospital of Boston, and the Joslin Diabetes Center.
Thomas Mac Mahon
Tom was Chairman, President and Chief Executive Officer of Laboratory Corporation of America (LabCorp) from 1997 until his retirement in December, 2006. Previously, he was President of Roche Diagnostics Group from 1988-1996. He currently serves on the Boards of LabCorp, Express Scripts, Inc. and PharMerica Corp. He also serves on the Boards of St. Peter's College and Elon University. He has an undergraduate degree from St. Peter's College (1968) and an MBA from Fairleigh Dickinson (1972).
Hemant Taneja, General Catalyst Partners, Managing Director
Hemant invests in healthcare, clean energy and internet communications. He is co-founder and Chairman of Sunborne Energy. Hemant co-founded Isovia, later acquired by JP Mobile (MOT). He co-founded and chairs the New England Clean Energy Council. He holds an M.S. in Operations Research, a BS and MEng in Electrical Engineering & Computer Science, and a BS in Mathematics, Biology & Biomedical Engineering from MIT.